RecruitingPhase 2NCT02479698
7
studies recruiting now
as of 7 Sept 2026
81
studies registered in total
as of 7 Sept 2026
9
countries with a recruiting site
as of 7 Sept 2026
23 Jan 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT02402244
Project: Every Child for Younger Patients With Cancer
RecruitingPhase 3NCT06500455
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
RecruitingNot applicableNCT06788886
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
RecruitingPhase 1 / Phase 2NCT06607692
Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 7 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Embryonal carcinoma of the central nervous system study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Embryonal carcinoma of the central nervous system
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).